Newsfeeds Archive - Spark Newswire

1 minute read

Charles River Laboratories In Collaboration With MatTek Awarded $1.3M Grant From The Foundation For Chemistry Research And Initiatives To Advance Research Alternatives

June 11, 8:19 AM

Project will utilize an integrated approach to develop an in vitro alternative to inhalation toxicology studiesCharles River Laboratories International, Inc. (NYSE:CRL) today announced a multidisciplinary program, funded

CRL

3 minute read

Analyst Ratings

The Analyst Verdict: Charles River In The Eyes Of 4 Experts

By Benzinga Insights

June 6, 9:00 AM

4 analysts have shared their evaluations of Charles River (NYSE:CRL) during the recent three months, expressing a mix…

CRL

4 minute read

Analyst Ratings

The Analyst Landscape: 7 Takes On Charles River

By Benzinga Insights

May 10, 8:00 AM

In the preceding three months, 7 analysts have released ratings for Charles River (NYSE:CRL), presenting a wide array…

CRL

5 minute read

Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights

May 7, 1:35 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

BMY

1 minute read

News

Charles River Launches Viral Vector Reference Materials To Streamline the Transition To GMP

By Benzinga Newsdesk

May 2, 8:14 AM

Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developersCharles River Laboratories International, Inc. (NYSE:CRL) today announced the launch of its reference

CRL

1 minute read

News

Charles River To Perform Plasmid Production For Ship Of Theseus

By Benzinga Newsdesk

April 4, 8:09 AM

GMP grade plasmid DNA to serve as a direct therapeutic targeting various indicationsCharles River Laboratories International, Inc. (NYSE:CRL) and Ship of Theseus, a therapeutics company developing degradation-resistant

CRL

2 minute read

Charles River Collaborates With Pluristyx, Expanding Its Portfolio Of Human Pluripotent Stem Cells

By Benzinga Newsdesk

February 20, 9:45 AM

The addition of ES cells and iPSCs will enhance Charles River's portfolio of powerful research tools supporting acceleration of therapeutic development.Charles River Laboratories International, Inc. (NYSE:CRL) today

CRL

3 minute read

Analyst Ratings

Forecasting The Future: 4 Analyst Projections For Charles River

By Benzinga Insights

February 15, 12:01 PM

During the last three months, 4 analysts shared their evaluations of Charles River (NYSE:CRL), revealing diverse outlooks from…

CRL

2 minute read

Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What’s Driving Markets Wednesday?

By Piero Cingari

February 14, 2:51 PM

The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.

ABNB

2 minute read

Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned

By Vandana Singh

February 14, 2:40 PM

Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance, keeping Outperform rating.

CRL